Investing.com - Financial Markets Worldwide

Oscar Health stock hits 52-week low at $12.26 amid challenges

Published 03/04/2025, 14:40
Oscar Health stock hits 52-week low at $12.26 amid challenges
OSCR
6.54%

Oscar Health, Inc. (OSCR) stock has touched a 52-week low, dipping to $12.26, as the company navigates through a tumultuous period in the healthcare sector. With a market capitalization of $3.12 billion and impressive revenue growth of 56.5% over the last twelve months, InvestingPro analysis suggests the stock is currently undervalued. This latest price level reflects a significant drop from previous valuations, underscoring the hurdles the company faces in a competitive and rapidly evolving industry. Over the past year, Oscar Health has seen its stock value decrease by 4.36%, while experiencing high price volatility and trading at an elevated P/E ratio of 152.7. The 52-week low serves as a critical indicator of the market’s current sentiment towards the health insurance provider and sets a new benchmark for its financial trajectory. Discover more insights and 10+ additional ProTips with InvestingPro’s comprehensive research report.

In other recent news, Oscar Health reported its fourth-quarter 2024 earnings, showing a slight miss in revenue expectations. The company generated $2.39 billion in revenue, falling short of the forecasted $2.46 billion, despite a 57% year-over-year increase in total revenue to $9.2 billion. Oscar Health achieved net income profitability, reporting $25 million in net income, and improved its adjusted EBITDA by $245 million year-over-year to $199 million. The company’s Medical (TASE:BLWV) Loss Ratio increased slightly to 81.7%. Looking ahead, Oscar Health provided a positive outlook for 2025, expecting total revenues between $11.2 billion and $11.3 billion. The company aims for earnings from operations between $225 million and $275 million. Analyst firms like Wells Fargo (NYSE:WFC) and Nephron Research engaged with Oscar Health during the earnings call, focusing on payment integrity and membership retention strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.